Data / Form D filings / Coeptis Therapeutics Holdings, Inc.
Coeptis Therapeutics Holdings, Inc.: Form D filings
Coeptis Therapeutics Holdings, Inc., a pharmaceuticals company in Wexford, PA, filed 3 Form D notices with the SEC between 2023 and 2025. The latest, on August 7, 2025, reports $4 million sold of a $5 million offering to 9 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 105 BRADFORD ROAD, SUITE 420, Wexford, PA, 15090
- Phone
- (724) 934-6467
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2022
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1759186
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 7, 2025 | New notice | $5,000,000 | $4,000,000 | $1,000,000 | 9 | Jul 24, 2025 | sec.gov |
| Jun 27, 2024 | New notice | $10,000,000 | $4,300,000 | $5,700,000 | 7 | Jun 14, 2024 | sec.gov |
| Nov 3, 2023 | New notice | $2,000,000 | $2,000,000 | 1 | Oct 26, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Christopher Cochran | Director | |
| David Mehalick | Executive Officer, Director | |
| Christopher Calise | Director | |
| Tara Maria DeSilva | Director | |
| Daniel Yerace | Director | |
| Brian Cogley | Executive Officer | |
| Gene Maria Salkind | Director | |
| Philippe Maria Deschamps | Director |
Other pharmaceuticals companies in Pennsylvania that filed recently
- Telemachus Therapeutics, Inc. $375,000 · Oct 28, 2026
- EpiVario Inc. $185,000 · Oct 13, 2026
- Maxona Pharmaceuticals, Inc. $5.8 million · Aug 14, 2026
- PLEOPHARMA, INC. $5.5 million · Aug 10, 2026
- Duo Oncology Inc. $1.6 million · Aug 7, 2026
Every Form D from the week of Aug 4, 2025 · All recent filings in Pennsylvania · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Coeptis Therapeutics Holdings, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.